Annual Working Capital
-$9.26 M
-$3.20 M-52.87%
December 31, 2023
Summary
- As of February 7, 2025, PBLA annual working capital is -$9.26 million, with the most recent change of -$3.20 million (-52.87%) on December 31, 2023.
- During the last 3 years, PBLA annual working capital has fallen by -$17.65 million (-210.32%).
- PBLA annual working capital is now -196.25% below its all-time high of $9.62 million, reached on December 31, 2021.
Performance
PBLA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$14.97 M
+$1.04 M+6.51%
September 30, 2024
Summary
- As of February 7, 2025, PBLA quarterly working capital is -$14.97 million, with the most recent change of +$1.04 million (+6.51%) on September 30, 2024.
- Over the past year, PBLA quarterly working capital has dropped by -$5.72 million (-61.74%).
- PBLA quarterly working capital is now -211.66% below its all-time high of $13.41 million, reached on September 30, 2021.
Performance
PBLA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
PBLA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.9% | -61.7% |
| 3 y3 years | -210.3% | -682.8% |
| 5 y5 years | -4366.4% | -682.8% |
PBLA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -196.3% | at low | -255.7% | +6.5% |
| 5 y | 5-year | -196.3% | at low | -211.7% | +6.5% |
| alltime | all time | -196.3% | at low | -211.7% | +6.5% |
Panbela Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$14.97 M(-6.5%) |
| Jun 2024 | - | -$16.02 M(+83.4%) |
| Mar 2024 | - | -$8.73 M(-5.7%) |
| Dec 2023 | -$9.26 M(+52.9%) | -$9.26 M(+31.7%) |
| Sep 2023 | - | -$7.03 M(-2868.1%) |
| Jun 2023 | - | $254.00 K(-113.3%) |
| Mar 2023 | - | -$1.91 M(-68.4%) |
| Dec 2022 | -$6.06 M(-163.0%) | -$6.06 M(-2.1%) |
| Sep 2022 | - | -$6.19 M(+125.4%) |
| Jun 2022 | - | -$2.75 M(-180.1%) |
| Mar 2022 | - | $3.43 M(-64.4%) |
| Dec 2021 | $9.62 M(+14.6%) | $9.62 M(-28.3%) |
| Sep 2021 | - | $13.41 M(+129.3%) |
| Jun 2021 | - | $5.85 M(-22.3%) |
| Mar 2021 | - | $7.53 M(-10.3%) |
| Dec 2020 | $8.39 M(+529.1%) | $8.39 M(-11.6%) |
| Sep 2020 | - | $9.50 M(+512.3%) |
| Jun 2020 | - | $1.55 M(+128.4%) |
| Mar 2020 | - | $679.00 K(-49.1%) |
| Dec 2019 | $1.33 M(+514.7%) | $1.33 M(-56.7%) |
| Sep 2019 | - | $3.08 M(+436.9%) |
| Jun 2019 | - | $574.00 K(-189.8%) |
| Mar 2019 | - | -$639.00 K(-394.5%) |
| Dec 2018 | $217.00 K | $217.00 K(-136.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -$595.00 K(-1181.8%) |
| Jun 2018 | - | $55.00 K(-102.6%) |
| Mar 2018 | - | -$2.13 M(-37.5%) |
| Dec 2017 | -$3.40 M(-26.7%) | -$3.40 M(+452.4%) |
| Sep 2017 | - | -$616.00 K(+156.7%) |
| Jun 2017 | - | -$240.00 K(-141.0%) |
| Mar 2017 | - | $585.00 K(-112.6%) |
| Dec 2016 | -$4.64 M(-1400.3%) | -$4.64 M(+964.7%) |
| Sep 2016 | - | -$436.00 K(-204.1%) |
| Jun 2016 | - | $419.00 K(-191.7%) |
| Mar 2016 | - | -$457.00 K(-228.0%) |
| Dec 2015 | $357.00 K(-81.3%) | $357.00 K(-65.6%) |
| Sep 2015 | - | $1.04 M(-370.7%) |
| Jun 2015 | - | -$383.80 K(+26.2%) |
| Mar 2015 | - | -$304.20 K(-116.0%) |
| Dec 2014 | $1.91 M(-925.5%) | $1.91 M(-587.8%) |
| Sep 2014 | - | -$390.70 K(+30.3%) |
| Jun 2014 | - | -$299.80 K(+4.3%) |
| Mar 2014 | - | -$287.40 K(+24.5%) |
| Dec 2013 | -$230.90 K(-24.7%) | -$230.90 K(-10.6%) |
| Sep 2013 | - | -$258.30 K(-3.6%) |
| Jun 2013 | - | -$267.90 K(-12.7%) |
| Mar 2013 | - | -$306.80 K(+0.0%) |
| Dec 2012 | -$306.70 K(-25.4%) | -$306.70 K |
| Dec 2011 | -$411.00 K | - |
FAQ
- What is Panbela Therapeutics annual working capital?
- What is the all time high annual working capital for Panbela Therapeutics?
- What is Panbela Therapeutics annual working capital year-on-year change?
- What is Panbela Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Panbela Therapeutics?
- What is Panbela Therapeutics quarterly working capital year-on-year change?
What is Panbela Therapeutics annual working capital?
The current annual working capital of PBLA is -$9.26 M
What is the all time high annual working capital for Panbela Therapeutics?
Panbela Therapeutics all-time high annual working capital is $9.62 M
What is Panbela Therapeutics annual working capital year-on-year change?
Over the past year, PBLA annual working capital has changed by -$3.20 M (-52.87%)
What is Panbela Therapeutics quarterly working capital?
The current quarterly working capital of PBLA is -$14.97 M
What is the all time high quarterly working capital for Panbela Therapeutics?
Panbela Therapeutics all-time high quarterly working capital is $13.41 M
What is Panbela Therapeutics quarterly working capital year-on-year change?
Over the past year, PBLA quarterly working capital has changed by -$5.72 M (-61.74%)